This is a case presentation of a 12-year-old girl who presented with bilateral ptosis, facial weakness, difficulty swallowing, and some hearing impairment that developed over 7 years. Examinations and tests showed signs of bulbar motor neuron involvement but normal muscle enzymes and nerve conduction studies. A review of literature on spinal muscular atrophy types suggests this patient has Type I bulbar SMA, characterized by sensorineural deafness and slow progression of bulbar palsy and weakness. Genetic testing may help confirm the diagnosis. Supportive management focuses on physical therapy and assisted ventilation if needed.
This presentation briefs out the approach of dementia assessment in line with consideration of recent advances. Now the pattern of assessment has evolved towards examining each individual domain rather than lobar assessment.
This presentation briefs out the approach of dementia assessment in line with consideration of recent advances. Now the pattern of assessment has evolved towards examining each individual domain rather than lobar assessment.
MANAGEMENT OF GUILLAIN BARRE SYNDROME THROUGH AYURVEDA-A CASE STUDY Dr Amritha Edayilliam
Guillain-Barré syndrome (GBS) is an acute, rapidly evolving are flexic motor paralysis with or without sensory disturbance. It occurs year around at arate of between 1 and 4 cases per 100,000 annually. Age is an important factor determining outcome, and prognosis.Direct correlation of GBS with Ayurvedic terminology is difficul. Here a case of 7 year old female child presented with sudden onset of loss of power in lower limb, unable to get up, walk and stand with a past history of fever brought to OPD of SKAMC&HRC Bangalore. She was provisionally diagnosed as a case of acute inflammatory demyelinating polyneuropathy (AIDP-type of GBS). As per Ayurvedic classics, this condition we have taken as Sarvangavata (Vata affecting the whole body) which precedes Jwara (H/O fever before onset of symptoms). Hence, the line of treatment we have adopted Jwara Chikitsa and Vatavyadhichikitsa which included Aamapachana as well as Brihmanachikitsa along with Shamanoushadhis. The outcome was very remarkable with the patient able to walk on her own.
GB Syndrome is an inflammatory disease, incidence is rising sharply in Pakistan, it needs epidemiological investigation and extensive search for reason of this endemic status.
Guillain-Barre Syndrome, Neuralgia, ALS -- By Prof. Dr. R. R. Deshpande
• This PPT – is about 3 rare but important diseases .As there is no satisfactory Treatments in Modem Medicine ,many patients come for Ayurvedic Treatment .So Ayurvedic students must understand these diseases .Also these diseases are included in CCIM syllabus of Kayachikitsa in 4th Year BAMS .This PPT will tell you causes ,Clinical features,Investigations ,Treatments for these 3 diseases .Even Ayurvedic Treatments are also given
• Visit – www.ayurvedicfriend.com
• Phone – 922 68 10 630
Myocardial Infarction - Case Presentation and an OverviewAbubakkar Raheel
Case Presented by Final Year MBBS sudents of Frontier Medical College at the 1st Clinico-Pathological Conference for the year 2015.The Presentation is divided into two parts. First part is about a case of an Acute ST Segment elevated Myocardial Infarction with. Its management at the Hospital and the findings. Second part is about the pathophysiology, Cinical signs and symptoms and an effective gold standard treatment of MI.
In this slideshow, we covered most of neuromuscular disorders which might face you in medicine in general and in pediatrics in particular.
We hope if you find this slideshow helpful for your seeking of this subject.
Cheers,
1. Case Presentation DR. HASSAB EL-RASOUL SIDDIG UNIT Omdurman Military Hospital Presented By: Dr. Kamal Abdel Azeem
2. Name : صفاء حمد عبدالرحمن Age : 12 years Sex : Female Residence : شندي Tribe : شايقية D.O.A : 28.8.03 C/O: Difficulty hearing Facial weakness Difficulty swallowing Difficulty speaking 7yrs
3. HPI: The pt. was an outcome of NVD at home, cried after resuscitation & took the breast. She passed through a normal milestones & fully vaccinated. At the age of 5yrs, she developed difficulty hearing and a few days later facial weakness. She was noticed to have inability to raise her brows or open her eyes. The condition associated with difficulty swallowing, especially fluids.
4. There was also difficulty speaking, her speech was low tone. No fluctuation in weakness was noticed. The whole process was not preceded by trauma, fever, sore throat, fatigability, nasal or ear discharge. No convulsion, abnormal movement, headache or syncopal attacks. No disturbance of smell. No UL, LL or truncal weakness. No sphincter disturbance.
14. Summary This is a 12 years old girl with bilateral ptosis,and facial and bulbar weakness and some hearing impairment of rapidly progressive course of 7 years duration. No family history of similar condition.
26. Types: (A) Proximal limb involvement. I) Acute infantile SMA (Werdnig Hoffman) (AR). II) Chronic childhood SMA (Kugelberg Welander) (AR). III) Adult onset SMA (AR). IV) AD juvenile SMA. V) AD adults SMA. (B) Distal limb involvement 7 various forms which are indistinguishable from HSMN I,II (Charcot Marie Tooth). (C) Bulbo spinal form (Kennedy Syndrome) x-linked.
27. (D) Occulo pharyngeal – AD. (E) Bulbar SMA (AR). Type I : (With deafness) Vialetto-Van Laere syndrome. Type II : (Without deafness) Fazio-Londe disease. We believe our patient has bulbar SMA Type I, first reported by Vialetto in 1936 and later in 1966 by Van Laere. Onset is before age 20.
28. Characterized by sensorineural deafness. There is facial weakness with dysarthria, dysphagia (bulbar palsy). The progression is slow and course variable. Some patients reach adulthood. There may be generalized weakness with hypotonia and wasting. Reflexes in limbs are present. NCS + EMG demonstrate signs of AHC disease.
29.
30.
31.
32. Areas of Research: A) Genetic studies. 2 genes have been identify on chromosome 5 q : the survival motor neuron (SMN) gene, & (NAIP). the neuronal apoptosis inhibition protein as the names imply abnormalities in those genes (deletion) lead to neuronal death. B) Prenatal prediction & diagnosis of affected foetuses in families with the disease.